Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Conjupro Biotherapeutics, Inc.
Filamon LTD
Atavistik Bio, Inc
Astellas Pharma Inc
PMV Pharmaceuticals, Inc
AstraZeneca
Roswell Park Cancer Institute
University of Michigan Rogel Cancer Center
Alterome Therapeutics, Inc.
Hoffmann-La Roche
Rutgers, The State University of New Jersey
Eli Lilly and Company
BeOne Medicines
Bayer
Monte Rosa Therapeutics, Inc
Psyence Australia Pty Ltd
ViroMissile, Inc.
University of Virginia
Dana-Farber Cancer Institute
Jazz Pharmaceuticals
Kaiser Permanente
Case Comprehensive Cancer Center
Institute of Oncology Ljubljana
Novartis
Duke University
University of Florida
AstraZeneca
Myeloid Therapeutics
Tizona Therapeutics, Inc
University of Florida
Essen Biotech
Essen Biotech
Leiden University Medical Center
Clasp Therapeutics, Inc.
Columbia University
Angiex, Inc.
Wake Forest University Health Sciences
Sapience Therapeutics
Poseida Therapeutics, Inc.
IDEAYA Biosciences
Ottawa Hospital Research Institute
Baylor College of Medicine
Memorial Sloan Kettering Cancer Center
University of Colorado, Denver
MacroGenics
University of Colorado, Denver
Avacta Life Sciences Ltd
Centre Paul Strauss